A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent.
暂无分享,去创建一个
B. Rodda | R. Wolen | A. Ridolfo | C. Gruber | L. Helleberg | A. Rubin
[1] R. Wolen,et al. Physiological disposition of fenoprofen in man. 3. Metabolism and protein binding of fenoprofen. , 1972, The Journal of pharmacology and experimental therapeutics.
[2] B. Rodda,et al. Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration. , 1972, Journal of pharmaceutical sciences.
[3] M Lappé,et al. Genetic control. , 1972, The New England journal of medicine.
[4] B. Rodda,et al. Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally. , 1971, Journal of pharmaceutical sciences.
[5] J. Nash,et al. GLC determination of dl-2-(3-phenoxyphenyl)propionic acid (Fenoprofen) in human plasma. , 1971, Journal of pharmaceutical sciences.
[6] E. Vesell,et al. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. , 1969, The Journal of clinical investigation.
[7] H. Remmer. 461 Drugs as activators of drug enzymes , 1961 .
[8] B. Brodie,et al. The estimation of antipyrine in biological materials. , 1949, The Journal of biological chemistry.